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Background: Kenya is faced with an increasing challenge of co-morbid psychological and social factors among HIV-
Infected patients which has had a profound impact on their medication adherence. A major psychosocial factor that is 
a barrier in adherence is depression associated with HIV. This study aimed at measuring the effect of depression on 
participants’ own reported adherence to antiretroviral therapy. 
Objectives: To determine the impact depression has had on adherence to antiretroviral therapy among HIV-infected 
patients at a Kenyatta Hospital. 
Methodology: A cross-sectional study design was carried out at Kenyatta National Hospital, Nairobi, Kenya. Three 
hundred and eighty four (384) HIV infected participants were assessed for HIV related depression and adherence to 
ART.  Levels of HIV related depression and adherence to ART were ascertained. 
Results: The prevalence of depression was 23.3 %.  The prevalence of mild, moderate and severe depression was 21.2 
%, 1.8 % and 0.3 % respectively. The mean non adherence and average mean adherence rate were 27.9 % and 22.4 % 
respectively. 
Conclusion:  There was a minimal relationship between depression and non-adherence to antiretroviral therapy 
among adult HIV infected patients. Depression was not statistically significantly associated with adherence to 
antiretroviral therapy.  
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1. Introduction 
According to a 2011 United Nations (UN) report, 
approximately 34 million of the World’s population 
were living with HIV/AIDS, while the number of people 
who died from AIDS related causes was approximately 
1.75 Million, showing a rising number of new infections 
and an improved access to therapy. It continues to 
remain a leading pandemic in the world and 
antiretroviral medication has been scaled up to increase 
efforts to suppress the HIV replication and improve the 
quality of life of patients. (Cohen et al, 2008).   
The prevalence of HIV/AIDS in Kenya among adults 
who are 15-64 years old has been estimated to be about 
6.3 %. It is higher in women aged 15-49 years, (8.0 %), 
compared to men of the same age bracket, (4.3 %). 
(Kenya Demographic and Health Survey Country 
Report, 2008-9). 
 The number of people living with HIV/AIDS in Kenya in 
2011 was estimated to be between 1,500,000 to 
1,700,000. More than 91,000 Kenyan adults became 
infected in 2011, with 1 in every 200 Kenyan adults 
being newly infected yearly (UNAIDS 2011).   
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Efforts to tackle HIV/AIDS in Kenya have concentrated 
mainly on the creation of awareness, prevention and 
antiretroviral therapy.  
According to some studies, the most under-addressed 
patient-based factor is the effect that mental illnesses 
has had on adherence to ARV’s, with mental illnesses 
being associated with high risk behaviors (Goldman, 
2000). 
Depression that is associated with HIV/AIDS is a huge 
barrier in the provision of adequate treatment to 
HIV/AIDS. It is the most common psychosocial co-
morbidity of HIV infection that will affect treatment in 
patients on ARV’s, with a prevalence of 37% in people 
living with HIV/AIDS (PLWHA) in the world (Bing et al, 
2001). 
The current research was borne from observations that 
had been made of several patients who had defaulted 
from taking ARV’s, with several of them having seemed 
to have given up hope despite having being on 
medication for a while. The study therefore aimed to 
find out the impact that depression may have had on 
adherence to ARV’s by patients at Kenyatta National 
Hospital, Comprehensive Care Centre. 
2. Methodology 
2.1 Study design and site 
The study design was a cross sectional study design 
carried out at the Comprehensive Care Centre of 
Kenyatta National Hospital in Nairobi, Kenya. It is the 
largest referral hospital in Kenya hosting the first 
pioneer centre for management of HIV/AIDS.  
2.2 Target population  
The target population was male and female adult 
patients aged 18 years old and above, who were HIV 
infected, were on ARV’s and were not on any 
antidepressants medication. 
2.3 Eligibility criteria 
Both male and female adult HIV infected patients who 
were enrolled at the KNH CCC, were above 18 years old, 
on antiretroviral therapy for one month or more, were 
not on antidepressant medication and were ready to 
give an informed consent were included in the study. 
Participants who did not meet the inclusion criteria 
were excluded from the study. 
2.4 Sampling 
Sample size was calculated using the Fischer’s formula. 
The desired sample size of 384 was identified through 
simple random sampling. 
 
2.5 Data collection 
A researcher designed socio demographic questionnaire 
to assess the patient details and PHQ-9 was employed in 
the study to assess the levels of depression. Adherence 
rates to ARV’s were assessed using pill count; the 
number of unused pills in patient’s possession plus no 
of missed days in a week.  
The Patient Health Questionnaire (PHQ) is a new 
instrument for making criteria-based diagnoses of 
depressive and other mental disorders commonly 
encountered in primary care. It is half the length of 
many other depression measures, has comparable 
sensitivity and specificity, and consists of the actual 9 
criteria upon which the diagnosis of depressive 
disorders is based. (Spitzer et al, 1999) 
As there is no gold standard for measurement of 
adherence, the prevalence of mean adherence to ARV’s 
over one month and mean adherence rate over three 
months were investigated in order to rule out instances 
of recall bias. Adherence to ARV’s was set at 95 % 
adherence as this level is required to be able to achieve 
optimal viral suppression.  
2.6 Data quality control 
Three pre-test participants were recruited and a test 
interview was conducted. The Management Sciences for 
Health tool for antiretroviral drugs dispensing (MSH-
ARV) was pre-tested and data compared with sampled 
physical data to ascertain its validity. 
The MSH-ARV tool is a software tool that stores data on 
the quantities of drug doses dispensed to HIV infected 
patients. Participants who were non-adherent to their 
medication were identified using the data stored in the 
tool.  
A perusal of the pill count records from the MSH-ARV 
dispensing tool was done and those who had missed 
their appointment dates were identified and percentage 
adherence rates (ADR %) calculated.  
2.7 Variables and Case definitions 
Depression associated with HIV was the independent 
variable while adherence to antiretroviral drugs was 
the dependent variable. 
Adherence was defined is the extent to which a person’s 
behaviour while taking medication, following a diet, 
and/or executing lifestyle changes, corresponds with 
agreed recommendations from a health care provider.     
Depression was defined as any mental state or chronic 
mental disorder characterized by feelings of sadness, 
loneliness, despair, low self-esteem, and self-reproach; 
accompanying signs include psychomotor retardation 
(or less frequently agitation), withdrawal from social 
contact, and vegetative states such as loss of appetite 
and insomnia. 
2.8 Data analysis 
Filled questionnaire forms were accessible only to the 
investigator and were kept safely and later analysed 
using the SPSS 17.0 software and the results were 
presented in the form of tables, pie and bar charts.  
Measures of central tendencies for the socio-
demographic data were calculated. Statistical 
significance will be set at p values of ≤0.05.  
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2.9 Ethical considerations 
The study commenced upon approval from the 
UON/KNH ERC vide approval number KNH-
ERC/A/199. The researcher further sought permission 
before commencing the research from the hospital 
management and the KNH CCC in-charge. Informed 
written consent by the participants prior to 
administering the study tools was obtained. One 
participant (was diagnosed to suffer from severe 
depression) and 7 participants (diagnosed to suffer 
from moderate depression) were referred to mental 
health workers for further treatment.  
 
       Table 1: Socio demographic characteristics of research participants 
Demographic  characteristics Frequency (n) Percent (%) 
Gender 
  
         Male 153 39.8 
         Female 231 60.2 
Age category 
  
         21-30 37 9.4 
         31-40 146 37.2 
         41-50 146 37.2 
         51-60 53 13.5 
         ≥ 61 10 2.6 
Marital status 
  
         Single 59 15.1 
         Married 234 59.8 
         Separated 32 8.2 
         Divorced 9 2.3 
         Widowed 57 14.6 
Number of children 
  
         0 27 6.9 
         1-2 186 47.5 
         3-4 128 32.6 
         5-6 39 10 
         ≥7 12 3.1 
Highest level of education 
  
         None 6 1.5 
         Primary 96 24.6 
         Secondary 187 47.9 
         College 74 19 
         University 23 5.9 
         Other 4 1 
Religion 
  
         Muslim 12 3.1 
         Christian 379 96.7 
         Traditional African 1 0.3 
Employment 
  
         Yes 356 42.3 
         No 33 8.4 
         Self employed 193 49.2 
Monthly income range(Kshs) 
  
          < 5000 97 27.3 
         5000-10000 97 27.3 
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3.  Results 
3.1 Socio demographic characteristics  
A total of 384 adult HIV/AIDS infected participants who 
matched the inclusion criteria were recruited in the 
month of August-September 2013 for the study.  
The median age was 31.5 years, with most participants 
in the middle age groups of 31-40 years (37.2 %) and 
41-50 years old (37.2 %), as illustrated in Table 1. More 
females, 60.2 % (n=231), participated in the study 
compared to 39.8 % (n=153) males, giving a female: 
male ratio of 3:2. This was because more females were 
willing to fill the consent form and respond to the 
questionnaires compared to the males who were 
reluctant to participate in the study.  
3.2 Prevalence of depression  
As per the PHQ-9 assessment, the proportion of patients 
who had depression was 23.3%. Of these, the 
distribution between mild, moderate and severe 
depression is as depicted in Table 2. 
3.3 Prevalence of adherence to ARV therapy 
among participants 
The mean adherence rate over a period of one month 
was 71.2 % of the participants while 27.9 % were found 
to be non-adherent. Similarly, the average mean 
adherence rate over a period of 3 months was observed 
to be 76.3 %, while 22.4 % were found to be non-
adherent indicating that the number of non-adherent 
patients after using antiretroviral drugs for three 
months decreased compared with those who used the 
drugs over a period of one month 
3.4 Association between depression and socio-
demographics  
There was a significant association between gender and 
depression, (χ2=8.857, p value=0.031), with more 
women, (73%), being depressed compared to men, 
(27%).  
A significant association (χ2= 19.995, p=0.01) between a 
patient’s marital status and the level of depression was 
observed indicating that married HIV infected patients 
are more likely to suffer from lower depression levels 
compared to unmarried patients. There was no 
significant association between the level of depression 
and the other socio demographic factors 
3.5 Association between adherence and socio-
demographic factors 
There was a significant relationship, (χ2= 8.558, 
p=0.03), between the employment status and the mean 
adherence rate over 1 month and the average mean 
adherence rate over a period of 3 months, (χ2= 5.712, 
p=0.017). 
The income range and mean adherence had a significant 
relationship, (χ2= 6.476, p=0.039), for the average mean 
adherence rate over 3 months. More participants who 
were employed were adherent to their medication 
compared to unemployed participants. 
Both the mean monthly and average mean adherence 
over three months showed statistical significance (χ2= 
9.797, p=0.044) and (χ2= 9.161, p=0.057) respectively, 
for the age category respectively. A majority of the 
patients (74.4%) were in the reproductive age group of 
21-50 years old, suggesting that they are more aware of 
their treatment regimens and HIV/AIDS status.  
This suggests that middle aged patients are more 
adherent to ARV’s compared with young and senile 
patients, who are more likely to suffer from 
stigmatisation and senility respectively. 
3.6 Relationship between depression and mean 
adherence rate  
Depression and mean adherence over one month did 
not have a statistically significant relationship (χ2= 
9.161, p=0.057). 
Similarly, there was also no statistically significant 
relationship (χ2= 9.161, p=0.051) between depression 
among HIV infected participants and the average mean 
adherence rate over 3 months. 
 
      Table 2: Prevalence of depression among HIV infected participants 
Score Frequency Percent Cumulative Percent 
0-4  (No depression) 301 76.8 76.8 
5 - 9 (Mild depression) 83 21.2 98 
10 – 14 (Moderate depression) 7 1.8 99.7 
>= 15 (Severe depression) 1 0.3 100 
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4. Discussion 
This study on the impact of depression on ARV’s has 
demonstrated that depression symptoms are minimally 
associated with suboptimal adherence to ARV therapy. 
The results indicate that a proportion of adult HIV - 
infected participants who were on antiretroviral 
therapy do not adhere to their drugs as required due to 
several factors that includes incidences of depression 
which threatens efforts to achieve adequate 
suppression of the AIDS virus, with similar findings 
having been observed in previous studies done in the 
United States of America (Kacanek et al, 2010).   
4.1 Association between depression and socio 
demographic factors 
Gender and marital status significantly influenced 
depression among the recruited participants with more 
women than men participating in the study. Previous 
studies have indicated that 59 % of women in sub-
Saharan Africa are HIV infected (Kacanek et al, 2010).   
Women bear a greater social responsibility and are 
more likely to seek medical assistance in case of HIV 
infection. More women also have been observed to 
suffer from depression associated with HIV compared 
to men (UNAIDS 2008).  
There was a significant association between a patient’s 
marital status and the level of depression with more 
participants being married while the rest were single, 
separated, divorced or widowed. Previous studies have 
indicated that married HIV infected patients are likely 
to suffer from lower depression levels compared to 
unmarried patients. (UNAIDS 2008). 
This may suggest that married patients are more likely 
to support one another in the management of HIV/AIDS 
hence have a lower likelihood of suffering from 
depression instances. 
4.2 Association between adherence and socio 
demographic factors 
A significant association between the age category of a 
patient and the mean adherence over one month and 
three months was observed. A majority of the patients 
(74.4%) were in the reproductive age group of 21-50 
years old, suggesting that they are more aware of their 
treatment regimens and HIV/AIDS status. This agrees 
with another study carried out in Central Province, 
Kenya, on the impact of psychosocial factors impact on 
adherence whereby 50 % of patients in the age group 
30-39 years were adherent to medication (Nyambura, 
2011). 
This suggests that middle aged patients are more 
adherent to ARV’s compared with young and senile 
patients, who are more likely to suffer from 
stigmatisation and senility respectively. 
More participants who were employed were adherent 
to their medication compared to unemployed 
participants. This may be explained by the fact that 
employed study participants are more likely to afford 
transport and manage to attend clinic appointments 
regularly compared with the unemployed participants. 
4.3 Prevalence of depression among adult HIV 
infected participants 
Among People Living with HIV/AIDS (PLWHA) in the 
United States of America (USA), it was observed that 
clinical depression has an estimated range of 
prevalence at 22-32 % (Orlando et al, 2002). Other 
studies have shown that depression among people 
living with HIV and AIDS in the world has a prevalence 
of 22 % (Komiti et al, 2003). This is a percentage which 
is close to the findings in this study. These figures are 
almost approximate with the findings in this study, 
whereby the prevalence of depression as measured by 
the PHQ-9 was found to be 27.9 % and 23.3 % for mean 
adherence rates of 1 month and 3 months average 
respectively.  
The depression levels have dropped from a high of 
47.25 % in 2011 to 23.3-27.9 %, with most patients who 
were depressed registering a moderate depression 
score of 1.8 % in 2013 compared to 25.25 % in 2011 
according to a similar study carried out at the CCC in 
KNH in 2011 to find out the prevalence of anxiety and 
depression. The overall prevalence of depression, 
although measured with a different instrument, the BDI, 
was then 47.25 %, with mild, moderate and severe 
depression accounting for 9.75 %, 25.25 % and 12.25 % 
respectively. This may suggest that efforts were done to 
address depression among PLWHA at the KNH CCC 
during this two year period (Ng'ang'a 2011). 
4.4 Prevalence of adherence  
As there is no gold standard for measurement of 
adherence, the prevalence of mean adherence to ARV’s 
over one month and mean adherence rate over three 
months were investigated in order to rule out instances 
of recall bias. Adherence to ARV’s was set at 95 % 
adherence as this level is required to be able to achieve 
optimal viral suppression. (Paterson et al, 2000) 
The findings in this study (71.2 %-76.3 % adherent; 
22.4 %-27.9 %). A similar study had findings of 74 % 
and 26 % for mean adherence and mean non adherence 
rates respectively. These findings are relatively similar 
to adherence findings in this study (Nyambura, 2011)   
4.5 Impact of depression among participants on 
antiretroviral adherence 
The relationship between depression and non-
adherence was not statistically significant. The presence 
of depressive symptoms of poor appetite, fatigue and 
insomnia may be as a result of the antiretroviral 
therapy side effects or other psychosocial factors like 
stigma that may impact on a HIV patient’s access to 
antiretroviral medication.  
Finally, it is imperative to note that one participant (was 
diagnosed to suffer from severe depression) and 7 
participants (diagnosed to suffer from moderate 
depression) were referred to mental health workers for 
further treatment. 
5. Conclusion 
The findings of this study provide evidence of a minimal 
relationship between depression and non-adherence to 
antiretroviral therapy among adult HIV infected 
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patients. There may be a need to integrate mental 
health treatment programs in the management of 
HIV/AIDS. There may also be a need to ensure regular 
screening for depression among patients on ARV’s in 
comprehensive care centres based on the findings in 
this study. 
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